Skip to main content
editorial
. 2019 Jan 1;5(1):44–46. doi: 10.1016/S2055-6640(20)30278-8

Table 1.

Demographic and clinic characteristics of the cohort of women with PaHIV (total=119)

Pregnant* (total=17) Whole cohort (total=119)
Median age (years) (IQR) 25 (23–28) 20 (18–24)
Mean BMI (kg/m2) 21.74 24.18
Underweight (BMI <18.5 kg/m2) (n) 1 (6%) 4/93 (4%)
Overweight (BMI >25 kg/m2) (n) 1 (6%) 30/93 (32%)
Black or mixed ethnicity (n) 15 (88%) 100/119 (84%)
Median CD4 cell count at time of audit (cells/mm3) (IQR) 539 (285–737) 666 (479–853)
Median CD4 cell count at time of pregnancy (cells/mm3) (IQR) 439 (213–690)
Median nadir CD4 (cells/mm3) (IQR) 256 (70–390) 320 (148–479)
Undetectable VL <50 copies/mL at time of audit (n) 10 (59%) 93 (78%)
Individuals using alcohol (n) 8/14 (57%) 49/109 (45%)
Individuals smoking (n) 10 (59%) 26/113 (23%)
Median years ART exposure (IQR) 12 (9–15) 13 (9–17)
Exposed ever to AZT, ddI or d4T (n) 8 (47%) 50/95 (53%)
Previous AIDS-defining diagnosis (n) 6 (35%) 42/110 (38%)

AZT: zidovudine; BMI: body mass index; ddI: didanosine; d4T: stavudine; PaHIV: perinatally acquired HIV; VL: viral load.

*There were 26 pregnancies and 20 live births. All infants had tested HIV negative to date. Three women had been seen by fertility services prior to conception.